These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27475486)

  • 1. A comprehensive analysis of brachytherapy clinical trials over the past 15 years.
    Odei BC; Boothe D; Lloyd S; Gaffney DK
    Brachytherapy; 2016; 15(6):679-686. PubMed ID: 27475486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database.
    Cihoric N; Tsikkinis A; Miguelez CG; Strnad V; Soldatovic I; Ghadjar P; Jeremic B; Dal Pra A; Aebersold DM; Lössl K
    Radiat Oncol; 2016 Mar; 11():48. PubMed ID: 27005770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 20-Year Analysis of Clinical Trials Involving Proton Beam Therapy.
    Odei BCL; Boothe D; Keole SR; Vargas CE; Foote RL; Schild SE; Ashman JB
    Int J Part Ther; 2017; 3(3):398-406. PubMed ID: 31772989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.
    Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials.
    Peinemann F; Grouven U; Bartel C; Sauerland S; Borchers H; Pinkawa M; Heidenreich A; Lange S
    Eur Urol; 2011 Nov; 60(5):881-93. PubMed ID: 21763066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "decay" of brachytherapy use in tumors of the oral cavity: A population-based patterns of care and outcomes analysis from 1973 to 2012.
    Orton A; Boothe D; Gan M; Monroe MM; Hitchcock YJ; Lloyd S
    Brachytherapy; 2016; 15(6):851-858. PubMed ID: 27364872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.
    Galalae RM; Martinez A; Mate T; Mitchell C; Edmundson G; Nuernberg N; Eulau S; Gustafson G; Gribble M; Kovács G
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1048-55. PubMed ID: 15001244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
    Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
    Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer.
    Zaorsky NG; Den RB; Doyle LA; Dicker AP; Hurwitz MD
    Expert Rev Med Devices; 2013 Nov; 10(6):751-63. PubMed ID: 24195459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.
    King MT; Chen MH; Moran BJ; Braccioforte MH; Buzurovic I; Muralidhar V; Yang DD; Mouw KW; Devlin PM; D'Amico AV; Nguyen PL; Orio PF
    Urol Oncol; 2018 Apr; 36(4):157.e15-157.e20. PubMed ID: 29276060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.
    Ong WL; Evans SM; Millar JL
    J Med Imaging Radiat Oncol; 2018 Apr; 62(2):256-261. PubMed ID: 29271056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining use of brachytherapy for the treatment of prostate cancer.
    Mahmood U; Pugh T; Frank S; Levy L; Walker G; Haque W; Koshy M; Graber W; Swanson D; Hoffman K; Kuban D; Lee A
    Brachytherapy; 2014; 13(2):157-62. PubMed ID: 24050892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
    Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
    Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite.
    Zibelman M; Barth P; Handorf E; Smaldone MC; Kutikov A; Uzzo RG; Bilusic M; Plimack ER; Wong YN; Geynisman DM
    Clin Genitourin Cancer; 2015 Apr; 13(2):142-9. PubMed ID: 25450029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis.
    Pickles T; Keyes M; Morris WJ
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):43-9. PubMed ID: 19570619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.